Gynesonics Receives $43,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    604 Fifth Avenue Redwood City, CA 94063 USA
  • Company Description
    Gynesonics is a private company that is developing a novel, minimally invasive system to treat uterine fibroid tumors, The VizAblate system. Gynesonics’ disposable, hand-held device combines ultrasound imaging to allow the gynecologist to identify fibroids with radiofrequency energy to ablate the tumor.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The proceeds from the equity financing will be used to fund Gynesonics’ strategic clinical plan, which includes current and future trials in the U.S. and globally, key programs in operations and research and development, market adoption and to support global regulatory and reimbursement efforts for the Gynesonics technology platform, Sonata.
  • M&A Terms
  • Venture Investor
    Endeavour Vision
  • Venture Investor
    Abingworth Management
  • Venture Investor
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    HBM Bioventures
  • Venture Investor
    Correlation Ventures
  • Venture Investor
    Hercules Technology Growth Capital

Trending on Xconomy